(Q33928096)

30 July 2017

title

Insulin and analogue effects on protein degradation in different cell types. Dissociation between binding and activity (English)

1 reference

30 July 2017

Fawcett J

1

1 reference

30 July 2017

Hamel FG

2

1 reference

30 July 2017

Bennett RG

3

1 reference

30 July 2017

Vajo Z

4

1 reference

30 July 2017

Duckworth WC

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

14 December 2000

1 reference

Journal of Biological Chemistry

30 July 2017

published in

1 reference

30 July 2017

volume

276

1 reference

30 July 2017

issue

15

1 reference

30 July 2017

page(s)

11552-11558

1 reference

Hormonal regulation of human muscle protein metabolism

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Signalling pathways regulating protein turnover in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Proteases and proteolysis in the lysosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Structure and functions of the 20S and 26S proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Structure and physiological function of calpains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Giant proteases: beyond the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Degradation of methoxysuccinyl-phe-leu-phe-7-amido-4-trifluoromethyl coumarin (FLF) in cultured myotubes and HepG2 cells is proteasome- and calpain/calcium-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Reduced rates of proteolysis in transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Insulin degradation: progress and potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Insulin inhibition of protein degradation in cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

In vitro and in vivo potency of insulin analogues designed for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Selective Effects of Inhibitors of Hormone Processing on Insulin Action in Isolated Hepatocytes*

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Insulin stimulates myogenesis in a rat myoblast line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Mechanisms of Cellular Protein Catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Insulin inhibition of proteasome activity in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Differences in the cellular processing of AspB10 human insulin compared with human insulin and LysB28ProB29 human insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Insulin and IGF-I analogs: novel approaches to improved insulin pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Semisynthetic insulin analogues modified in positions B24, B25 and B29

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

[Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M007988200

21 January 2018

Identifiers

DOI

10.1074/JBC.M007988200

1 reference

30 July 2017

1 reference